abstract |
(E) -2- (5-chlorothien-2-yl) -N-{(3S) -1-[(1S) -1-methyl-2-morpholin-4-yl-2 in substantially crystalline form -Oxoethyl] -2-oxopyrrolidin-3-yl} ethenesulfonamide, a pharmaceutical formulation thereof, a method of preparation thereof, and a use thereof as a medicament, in particular for use in improving a clinical disease requiring a factor Xa inhibitor. do. |